EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

S100A9 Induces RANKL Expression in Osteocytes Utilizing IL ‐6/ sIL ‐ 6R Combination and gp130 Signaling Pathways

Eijiro Sakamoto iD, Tetsuya Yoshimoto, Rie Kido, Mikihito Kajiya iD, Hiromichi Yumoto

The FASEB Journal · 31.10.2026 · 40 (20)

DOI: 10.1096/fj.202603197r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 14.10.2026. Verfasst von Eijiro Sakamoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology and Endodontology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: RANK Ligand, Cytokine Receptor gp130, Osteocytes, Receptors, Interleukin-6. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MEXT | JSPS | Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calprotectin, a heterodimer of S100A8 and S100A9, is predominantly expressed in neutrophils, monocytes, and chondrocytes. Clinical studies demonstrate that elevated circulating calprotectin levels correlate with diseases followed by inflammatory bone loss, including rheumatoid arthritis, osteoarthritis, and periodontitis. We previously reported that S100A9 directly increased RANKL and IL‐6 expression in an osteocyte‐like cell line. While RANKL is well‐established as an essential factor for the formation and activation of osteoclasts, the role of S100A9‐induced IL‐6 in bone resorption remains unclear. On the other hand, osteocytes require sIL‐6R to activate the gp130 signaling pathway. Therefore, we hypothesized that S100A9‐induced IL‐6 cooperates with soluble IL‐6 receptor (sIL‐6R) to increase RANKL through gp130‐mediated signaling. Here, we show that S100A9 increases the bone resorption area and TRAP‐positive cell number in the murine calvaria. In addition, Rankl and Il6 mRNA levels in osteocytes were upregulated by S100A9 treatment. In vitro results demonstrated that S100A9 increased not only Rankl and Il6 expression in osteocytes, but also sIL‐6R secretion in macrophages. Since osteocytes strongly express gp130, the IL‐6 complexed with sIL‐6R enhanced gp130 downstream signaling, including JAK1 and STAT3 activation in osteocytes. Blockade of either Il6 or gp130 suppressed S100A‐induced effects. Notably, gp130 antagonist treatment inhibited S100A9‐induced bone resorption in vivo. Collectively, these findings suggest that S100A9 promotes RANKL‐mediated osteoclastogenesis through IL‐6/sIL‐6/gp130 signaling in osteocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RANK LigandCytokine Receptor gp130OsteocytesReceptors, Interleukin-6Interleukin-6Calgranulin BSignal TransductionAnimalsMiceBone ResorptionMice, Inbred C57BL

Stichwörter der Autor:innen

S100A9calprotectininterleukin‐6macrophageosteocytereceptor activator of nuclear factor‐κB ligandsoluble interleukin‐6 receptor

Substanzen

RANK LigandCytokine Receptor gp130Receptors, Interleukin-6Interleukin-6Calgranulin BTnfsf11 protein, mouseS100A9 protein, mouseIl6st protein, mouse

Autor:innen und Institutionen

  • Department of Periodontology and Endodontology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Department of Innovation and Precision Dentistry, Hiroshima University School of Dentistry, Hiroshima, Japan.
  • Department of Periodontology and Endodontology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

ORCID-Profile: Eijiro Sakamoto, Mikihito Kajiya

Förderung

  • MEXT | JSPS | Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Sakamoto, E., Yoshimoto, T., Kido, R., Kajiya, M., & Yumoto, H. (2026). S100A9 Induces RANKL Expression in Osteocytes Utilizing IL ‐6/ sIL ‐ 6R Combination and gp130 Signaling Pathways. The FASEB Journal, 40(20). https://doi.org/10.1096/fj.202603197r

Vancouver

Sakamoto E, Yoshimoto T, Kido R, Kajiya M, Yumoto H. S100A9 Induces RANKL Expression in Osteocytes Utilizing IL ‐6/ sIL ‐ 6R Combination and gp130 Signaling Pathways. The FASEB Journal. 2026;40(20). doi:10.1096/fj.202603197r

BibTeX
@article{Sakamoto2026,
  author = {Sakamoto, Eijiro and Yoshimoto, Tetsuya and Kido, Rie and Kajiya, Mikihito and Yumoto, Hiromichi},
  title = {S100A9 Induces RANKL Expression in Osteocytes Utilizing IL ‐6/ sIL ‐ 6R Combination and gp130 Signaling Pathways},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {20},
  doi = {10.1096/fj.202603197r}
}
Kostenlos starten →